Dosing of colistin - Back to basic PK/PD

Current Opinion in Pharmacology

Volumn 11, Issue 5, 2011, Pages 464-469

  Bergen, Phillip J ^a   Li, Jian ^a   Nation, Roger L ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIMETHATE; COLISTIN; PRODRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; CRITICALLY ILL PATIENT; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG EXCRETION; DRUG METABOLISM; HUMAN; KIDNEY DYSFUNCTION; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE EXCRETION; KLEBSIELLA PNEUMONIAE; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NEPHROTOXICITY; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 80053116134     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2011.07.004     Document Type: Review

References (43)

1. H.W. Boucher, G.H. Talbot, J.S. Bradley, J.E. Edwards, D. Gilbert, L.B. Rice, M. Scheld, B. Spellberg, and J. Bartlett Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America Clin Infect Dis 48 2009 1 12
2. G.H. Talbot, J. Bradley, J.E. Edwards Jr., D. Gilbert, M. Scheld, and J.G. Bartlett Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America Clin Infect Dis 42 2006 657 668 (Pubitemid 43271379)
3. M.E. Falagas, and I.A. Bliziotis Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int J Antimicrob Agents 29 2007 630 636 (Pubitemid 46710354)
4. R.L. Nation, and J. Li Colistin in the 21st century Curr Opin Infect Dis 22 2009 535 543
5. J. Li, R.L. Nation, J.D. Turnidge, R.W. Milne, K. Coulthard, C.R. Rayner, and D.L. Paterson Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections Lancet Infect Dis 6 2006 589 601
6. M.J. Richards, J.R. Edwards, D.H. Culver, and R.P. Gaynes Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System Crit Care Med 27 1999 887 892 (Pubitemid 29266004)
7. R.C. Spencer Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study Eur J Clin Microbiol Infect Dis 15 1996 281 285 (Pubitemid 26159687)
8. M.E. Falagas, P.I. Rafailidis, D.K. Matthaiou, S. Virtzili, D. Nikita, and A. Michalopoulos Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients Int J Antimicrob Agents 32 2008 450 454
9. J. Li, R.L. Nation, R.W. Milne, J.D. Turnidge, and K. Coulthard Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria Int J Antimicrob Agents 25 2005 11 25 (Pubitemid 40023341)
10. E.G. Beveridge, and A.J. Martin Sodium sulphomethyl derivatives of polymyxins Br J Pharmacol Chemother 29 1967 125 135
11. P.J. Bergen, J. Li, C.R. Rayner, and R.L. Nation Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa Antimicrob Agents Chemother 50 2006 1953 1958 (Pubitemid 43807511)
12. A. Walkty, M. DeCorby, K. Nichol, J.A. Karlowsky, D.J. Hoban, and G.G. Zhanel In vitro activity of colistin (polymyxin E) against 3,480 isolates of gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD study, 2007-2008 Antimicrob Agents Chemother 53 2009 4924 4926
13. J. Li, R.W. Milne, R.L. Nation, J.D. Turnidge, T.C. Smeaton, and K. Coulthard Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate J Antimicrob Chemother 53 2004 837 840 (Pubitemid 38660288)
14. S. Marchand, I. Lamarche, P. Gobin, and W. Couet Dose-ranging pharmacokinetics of colistin methanesulphonate (CMS) and colistin in rats following single intravenous CMS doses J Antimicrob Chemother 65 2010 1753 1758
15. J. Li, K. Coulthard, R. Milne, R.L. Nation, S. Conway, D. Peckham, C. Etherington, and J. Turnidge Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis J Antimicrob Chemother 52 2003 987 992 (Pubitemid 38008420)
16. J. Li, C.R. Rayner, R.L. Nation, R. Deans, R. Boots, N. Widdecombe, A. Douglas, and J. Lipman Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration Antimicrob Agents Chemother 49 2005 4814 4815 (Pubitemid 41552630)
17. D. Plachouras, M. Karvanen, L.E. Friberg, E. Papadomichelakis, A. Antoniadou, I. Tsangaris, I. Karaiskos, G. Poulakou, F. Kontopidou, and A. Armaganidis Population pharmacokinetic analysis of colistin methanesulphonate and colistin after intravenous administration in critically ill patients with gram-negative bacterial infections Antimicrob Agents Chemother 53 2009 3430 3436
18. J. Li, R.W. Milne, R.L. Nation, J.D. Turnidge, T.C. Smeaton, and K. Coulthard Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration Antimicrob Agents Chemother 47 2003 1766 1770 (Pubitemid 36548571)
19. Z. Ma, J. Wang, R.L. Nation, J. Li, J.D. Turnidge, K. Coulthard, and R.W. Milne Renal disposition of colistin in the isolated perfused rat kidney Antimicrob Agents Chemother 53 2009 2857 2864
20. A.C. Gales, R.N. Jones, and H.S. Sader Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004) Clin Microbiol Infect 12 2006 315 321 (Pubitemid 43337520)
21. J.B. Bulitta, J.C. Yang, L. Yohonn, N.S. Ly, S.V. Brown, R.E. D'Hondt, W.J. Jusko, A. Forrest, and B.T. Tsuji Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic model Antimicrob Agents Chemother 54 2010 2051 2062
22. B.W. Gunderson, K.H. Ibrahim, L.B. Hovde, T.L. Fromm, M.D. Reed, and J.C. Rotschafer Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model Antimicrob Agents Chemother 47 2003 905 909 (Pubitemid 36254214)
23. R.J. Owen, J. Li, R.L. Nation, and D. Spelman In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates J Antimicrob Chemother 59 2007 473 477 (Pubitemid 47073453)
24. A. Poudyal, B.P. Howden, J.M. Bell, W. Gao, R.J. Owen, J.D. Turnidge, R.L. Nation, and J. Li In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae J Antimicrob Chemother 62 2008 1311 1318
25. J. Li, J. Turnidge, R. Milne, R.L. Nation, and K. Coulthard In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis Antimicrob Agents Chemother 45 2001 781 785 (Pubitemid 32182025)
26. C.H. Tan, J. Li, and R.L. Nation Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model Antimicrob Agents Chemother 51 2007 3413 3415 (Pubitemid 350067568)
27. J. Li, C.R. Rayner, R.L. Nation, R.J. Owen, D. Spelman, K.E. Tan, and L. Liolios Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii Antimicrob Agents Chemother 50 2006 2946 2950 (Pubitemid 44396396)
28. S. Ketthireddy, D.G. Lee, Y. Murakami, T. Stamstad, D.R. Andes, and W.A. Craig In vivo pharmacodynamics of colistin against Pseudomonas aeruginosa in thighs of neutropenic mice (abstract A-4, p1) Abstracts of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Chicago, Illinois, September 17-20 2007 American Society for Microbiology
29. W. Yau, R.J. Owen, A. Poudyal, J.M. Bell, J.D. Turnidge, H.H. Yu, R.L. Nation, and J. Li Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme J Infect 58 2009 138 144
30. J. Li, R.L. Nation, R.J. Owen, S. Wong, D. Spelman, and C. Franklin Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains Clin Infect Dis 45 2007 594 598 (Pubitemid 47328640)
31. P.J. Bergen, J.B. Bulitta, A. Forrest, B.T. Tsuji, J. Li, and R.L. Nation Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model Antimicrob Agents Chemother 54 2010 3783 3789
32. R.V. Dudhani, J.D. Turnidge, K. Coulthard, R.W. Milne, C.R. Rayner, J. Li, and R.L. Nation Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models Antimicrob Agents Chemother 54 2010 1117 1124
33. R.V. Dudhani, J.D. Turnidge, R.L. Nation, and J. Li fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models J Antimicrob Chemother 65 2010 1984 1990
34. Clinical and Laboratory Standards Institute (CLSI): Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement (M100-S20). Wayne, PA; 2010.
35. N. Markou, S.L. Markantonis, E. Dimitrakis, D. Panidis, E. Boutzouka, S. Karatzas, P. Rafailidis, H. Apostolakos, and G. Baltopoulos Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study Clin Ther 30 2008 143 151 (Pubitemid 351834728)
36. R. Imberti, M. Cusato, P. Villani, L. Carnevale, G.A. Iotti, M. Langer, and M. Regazzi Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration Chest 138 2010 1333 1339
37. A. Kumar, D. Roberts, K.E. Wood, B. Light, J.E. Parrillo, S. Sharma, R. Suppes, D. Feinstein, S. Zanotti, and L. Taiberg Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock Crit Care Med 34 2006 1589 1596 (Pubitemid 43810035)
38. C.M. Luna, P. Aruj, M.S. Niederman, J. Garzon, D. Violi, A. Prignoni, F. Rios, S. Baquero, and S. Gando Appropriateness and delay to initiate therapy in ventilator-associated pneumonia Eur Respir J 27 2006 158 164 (Pubitemid 43092680)
39. P.J. Bergen, J. Li, R.L. Nation, J.D. Turnidge, K. Coulthard, and R.W. Milne Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model J Antimicrob Chemother 61 2008 636 642 (Pubitemid 351321139)
40. L.E. Friberg, I. Karaiskos, M. Karvanen, K. Pontikis, E. Papadomichelakis, D. Plachouras, A. Armaganidis, O. Cars, and H. Giamarellou Colistin pharmacokinetics after administration of a loading dose of colistin methanesulphonate (CMS) in critically ill patients with infection by multidrug-resistant Gram-negative bacteria (MDR-GNB) (abstract A1-665, p52) Abstracts of the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Boston, MA, September 12-15 2010 American Society for Microbiology
41. S.M. Garonzik, J. Li, V. Thamlikitkul, D.L. Paterson, S. Shoham, J. Jacob, F.P. Silveira, A. Forrest, and R.L. Nation Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients Antimicrob Agents Chemother 55 2011 3284 3294
42. R.L. Nation Towards optimized colistin dosing (Symposium presentation, p32) Abstracts of the 50th Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) Boston, Massachusetts, September 12-15 2010 American Society for Microbiology
43. S. Marchand, J.P. Frat, F. Petitpas, F. Lemaitre, P. Gobin, R. Robert, O. Mimoz, and W. Couet Removal of colistin during intermittent haemodialysis in two critically ill patients J Antimicrob Chemother 65 2010 1836 1837